Pfizer Says Long-Awaited Lyme Vaccine Was Effective in Study

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though fewer-than-expected cases in a study made it hard to determine how well it works on a large scale....

Redirecting to full article...